The company reported Q3 figures this morning - highlights from the report:Operating loss before tax for the third quarter of 2024amounted to kDKK -8,523 vs- (kDKK -8,484 - 2023). Operating loss before tax for the first nine months of 2024amounted to kDKK -30,002 vs. (kDKK -25,328 - 2023)Cash amounted to kDKK 7,938 We host event with management Monday 25th. at 11:30 AM - sign up here: Curasight Q3 event The exercise period for warrants of series TO2 starts today - see timeline here: The exercise price for TO2 has been set at DKK 11.50 per share. In the event of full utilization of warrants of series TO2, approximately DKK 42.4 million will be added to the Company before issue costs. If fully subscribed the dilution amounts to approximately 15.1 percent of the capital and votes. Disclaimer: HC Andersen Capital receives payment from the Curasight for a Digital IR/Corporate Visibility subscription agreement. Analyst Claus Thestrup 8:30 AM, 20.11.2024

info@inderes.fi (inderes.fi)

© Inderes Oyj. All rights reserved.